Alan H Fairlamb

Alan H Fairlamb

University of Dundee

H-index: 86

Europe-United Kingdom

About Alan H Fairlamb

Alan H Fairlamb, With an exceptional h-index of 86 and a recent h-index of 37 (since 2020), a distinguished researcher at University of Dundee, specializes in the field of Drug discovery / neglected diseases / parasitology / drug resistance / Leishmaniasis / Chagas' disease / African trypanosomiasis.

His recent articles reflect a diverse array of research interests and contributions to the field:

Validation of Trypanosoma cruzi inactivation techniques for laboratory use

Author Correction: Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis

The critical role of mode of action studies in kinetoplastid drug discovery

Monocyclic nitro-heteroaryl nitrones with dual mechanism of activation: synthesis and antileishmanial activity

Multiple unbiased approaches identify oxidosqualene cyclase as the molecular target of a promising anti-leishmanial

Tres Cantos Open Lab: celebrating a decade of innovation in collaboration to combat endemic infectious diseases

Surmounting structural barriers to tackle endemic infectious diseases

Emily Fong in WCAIR: Artist in digital residence

Alan H Fairlamb Information

University

Position

___

Citations(all)

33254

Citations(since 2020)

6994

Cited By

28681

hIndex(all)

86

hIndex(since 2020)

37

i10Index(all)

256

i10Index(since 2020)

136

Email

University Profile Page

University of Dundee

Google Scholar

View Google Scholar Profile

Alan H Fairlamb Skills & Research Interests

Drug discovery / neglected diseases / parasitology / drug resistance / Leishmaniasis / Chagas' disease / African trypanosomiasis

Top articles of Alan H Fairlamb

Title

Journal

Author(s)

Publication Date

Validation of Trypanosoma cruzi inactivation techniques for laboratory use

Plos one

Lorna M MacLean

Mark Ariyanayagam

Lalitha Sastry

Christy Paterson

Manu De Rycker

...

2024/4/18

Author Correction: Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis

Nature

Susan Wyllie

Michael Thomas

Stephen Patterson

Sabrinia Crouch

Manu De Rycker

...

2023/7

The critical role of mode of action studies in kinetoplastid drug discovery

Alan H Fairlamb

Susan Wyllie

2023/5/10

Monocyclic nitro-heteroaryl nitrones with dual mechanism of activation: synthesis and antileishmanial activity

ACS Medicinal Chemistry Letters

Juliana da Silva Pacheco

Debora de Souza Costa

Edézio Ferreira Cunha-Júnior

Valter Viana Andrade-Neto

Alan H Fairlamb

...

2021/8/16

Multiple unbiased approaches identify oxidosqualene cyclase as the molecular target of a promising anti-leishmanial

Cell chemical biology

Luciana S Paradela

Richard J Wall

Sandra Carvalho

Giulia Chemi

Victoriano Corpas-Lopez

...

2021/5/20

Tres Cantos Open Lab: celebrating a decade of innovation in collaboration to combat endemic infectious diseases

Felix Calderón

Lluis Ballell

David Barros

Graeme Bilbe

Nicholas Cammack

...

2021/11

Surmounting structural barriers to tackle endemic infectious diseases

Felix Calderón

Alan H Fairlamb

Mike Strange

Pauline Williams

Carl F Nathan

2021/8/19

Emily Fong in WCAIR: Artist in digital residence

Emily Fong

Alan Fairlamb

Paul Wyatt

Kevin Read

Mark Field

...

2020/8/11

Discovery of an allosteric binding site in kinetoplastid methionyl-tRNA synthetase

ACS infectious diseases

Leah S Torrie

David A Robinson

Michael G Thomas

Judith V Hobrath

Sharon M Shepherd

...

2020/4/10

New 8-Nitroquinolinone Derivative Displaying Submicromolar in Vitro Activities against Both Trypanosoma brucei and cruzi

ACS Medicinal Chemistry Letters

Julien Pedron

Clotilde Boudot

Jean-Yves Brossas

Emilie Pinault

Sandra Bourgeade-Delmas

...

2020/2/6

Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T. b. brucei hit-compound with improved pharmacokinetic …

European Journal of Medicinal Chemistry

Cyril Fersing

Clotilde Boudot

Romain Paoli-Lombardo

Nicolas Primas

Emilie Pinault

...

2020/11/15

The Qi Site of Cytochrome b is a Promiscuous Drug Target in Trypanosoma cruzi and Leishmania donovani

ACS infectious diseases

Richard J Wall

Sandra Carvalho

Rachel Milne

Juan A Bueren-Calabuig

Sonia Moniz

...

2020/1/22

8-Alkynyl-3-nitroimidazopyridines display potent antitrypanosomal activity against both T. b. brucei and cruzi

European Journal of Medicinal Chemistry

Cyril Fersing

Clotilde Boudot

Caroline Castera-Ducros

Emilie Pinault

Sébastien Hutter

...

2020/9/15

Para-site-seeing: Exhibition Catalogue

Ali Floyd

Holly Yeoman

Jen Southern

Rod Dillon

Sarah Cook

...

2020

Blog post. Emily Fong in WCAIR: Artist in digital residence

Emily Fong

Alan Fairlamb

Paul Wyatt

Kevin Read

Mark Field

...

2020/8/11

See List of Professors in Alan H Fairlamb University(University of Dundee)

Co-Authors

H-index: 81
Fred Opperdoes

Fred Opperdoes

Université Catholique de Louvain

H-index: 72
Christine Clayton

Christine Clayton

Heidelberg University

H-index: 61
Ian Gilbert

Ian Gilbert

University of Dundee

H-index: 61
William Nigel Hunter

William Nigel Hunter

University of Dundee

H-index: 38
Susan Wyllie

Susan Wyllie

University of Dundee

academic-engine